Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acidform Gel on Vaginal pH
NCT02693418Phase 1Completed
- Sponsor
- Evofem Biosciences, Inc.
- Start
- Aug 2016
- Primary completion
- Dec 2016
- Modality
- Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of Amphora in bacterial vaginosis (BV) (5 arms), sponsored by Evofem Biosciences, Inc. Primary endpoint: Change in Vaginal pH at Day 7. Started Aug 2016; status: completed.
02
Drugs
Amphora
03
Conditions
bacterial vaginosis (BV)
Beyond the preview
Go deeper on NCT02693418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02693418.